Neumann D R, Esselstyn C B, MacIntyre W J, Chen E Q, Go R T, Licata A A
Department of Nuclear Medicine (Division of Radiology), Cleveland Clinic Foundation, OH 44195-5074, USA.
J Comput Assist Tomogr. 1997 Jan-Feb;21(1):25-8. doi: 10.1097/00004728-199701000-00005.
The use of preoperative imaging studies in patients with persistent or recurrent hyperparathyroidism after initial operation is generally accepted to improve the success rate and minimize the morbidity from reoperative surgery. The purpose of this study was to define the performance of FDG-PET for the localization of hyperfunctioning parathyroid tissue prior to reoperation.
Twenty patients with biochemical evidence of recurrent or persistent hyperparathyroidism following previous neck surgery were investigated. Regional body PET imaging of the neck and upper chest (axial field of view 27.5 cm) was acquired 45 min after 5-10 mCi FDG was given intravenously.
Subsequent surgery revealed solitary parathyroid adenomas in 14 patients, seven hyperplastic glands in 2 patients, and parathyroid carcinoma in 1 patients. FDG-PET correctly identified 79% (11/14) of the parathyroid adenomas, 29% (2/7) of the hyperplastic glands, and the parathyroid carcinoma. FDG-PET was negative in 79% (30/38) of the surgically identified normal parathyroid glands. Eight false-positive findings led to a positive predictive value of 64%.
These preliminary data suggest that regional body FDG-PET is a promising procedure in the evaluation of patients with persistent or recurrent postoperative hyperparathyroidism.
初次手术后持续性或复发性甲状旁腺功能亢进患者使用术前影像学检查通常被认为可提高成功率并将再次手术的发病率降至最低。本研究的目的是确定FDG-PET在再次手术前定位功能亢进甲状旁腺组织的性能。
对20例先前颈部手术后有生化证据表明复发性或持续性甲状旁腺功能亢进的患者进行了研究。静脉注射5-10 mCi FDG后45分钟,对颈部和上胸部进行区域全身PET成像(轴向视野27.5 cm)。
随后的手术发现14例患者为孤立性甲状旁腺腺瘤,2例患者为7个增生性腺,1例患者为甲状旁腺癌。FDG-PET正确识别了79%(11/14)的甲状旁腺腺瘤、29%(2/7)的增生性腺和甲状旁腺癌。在手术确定的正常甲状旁腺中,79%(30/38)的FDG-PET结果为阴性。8例假阳性结果导致阳性预测值为64%。
这些初步数据表明,区域全身FDG-PET在评估术后持续性或复发性甲状旁腺功能亢进患者方面是一种有前景的方法。